Nomikos George 4
4 · Lipocine Inc. · Filed Nov 8, 2022
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Nomikos George
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-11-01$0.41/sh+125,000$50,750→ 125,000 totalExercise: $0.41From: 2023-11-01Exp: 2032-11-01→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of November 1, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years.